R. Loch Macdonald, Chief Scientific Officer at Edge Therapeutics, Inc. (EDGE), sold 2,500 shares at $16.41 ($41K) on 2018-03-22, disclosed to the SEC on 2018-03-22.
Scheduled sale ($41k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |